Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors

NCT02608606 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Evidence of Liver Transplantation
Effects of Immunosuppressant Therapy

Interventions

DRUG: Tacrolimus

Sponsor

Pontificia Universidad Catolica de Chile